"It’s a privilege to join Compass Pathways at such a pivotal moment, and to help advance innovation in mental health care for patients living with difficult-to-treat mental health conditions who desperately need new options."

Mike Gold

Chief Research and Development Officer

Mike is a passionate and highly effective pharmaceutical executive, bringing more than 25 years of experience across all aspects of drug development in neuroscience to Compass. Before joining Compass, he was Chief Medical Officer at Neumora Therapeutics.  

Mike has substantial therapeutic experience in neurological disorders and psychiatric disorders, including depression. He has worked extensively with small molecules, biologicals, drug-device combinations, diagnostics and various types of biomarkers. He has significant experience in all segments of the pharmaceutical/biotechnology sector, including large, small, specialty, start-up and CRO companies. Mike is a highly respected leader in neuroscience drug development and sits on multiple advisory boards. He was selected by the FDA to be the industry representative for advisory committees of the Office of Neuroscience. 

"It’s a privilege to join Compass Pathways at such a pivotal moment, and to help advance innovation in mental health care for patients living with difficult-to-treat mental health conditions who desperately need new options."
Back to Our Team